FDA Approved: EVEROLIMUS — Original Application (Novugen Pharma (USA) LLC.)

View source ↗

Summary

FDA approved a generic version of Everolimus from Novugen Pharma (USA) LLC under an Original Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Receptor-positive Breast Cancer
• Pancreatic Neuroendocrine Tumor
• Renal Cell Carcinoma
• Tuberous Sclerosis Complex-associated Renal Angiomyolipoma
• Tuberous Sclerosis Complex-associated Subependymal Giant Cell Astrocytoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

ORIG AP for EVEROLIMUS (EVEROLIMUS)